4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001193125-25-321122
Chief Scientific Officer sold 3,143 shares at an average $12.23 ($38,433)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Michaelson Jennifer · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-12 | Sale : show line 1 in the form 10b5-1 | −2,148 | $12.38 | $26,592 | 137,873 | D |
| 2025-12-15 | Sale : show line 2 in the form 10b5-1 | −995 | $11.90 | $11,841 | 136,878 | D |
| Open-market sales · 3,143 sh · avg $12.23 · $38,433 | ||||||
Loading xslF345X05/ownership.xml…